The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Non Hodgkin Lymphoma
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Newly diagnosed non-Hodgkin lymphoma (NHL) patients will be recruited from each center participating in the LEO cohort. At time of consent, participants will be asked to completed several questionnaires collecting health history, current medical and quality of life questions. Patients will also prov...
Newly diagnosed non-Hodgkin lymphoma (NHL) patients will be recruited from each center participating in the LEO cohort. At time of consent, participants will be asked to completed several questionnaires collecting health history, current medical and quality of life questions. Patients will also provide a baseline blood sample that will processed locally and stored centrally for future research use. Additionally, consent is given for use of excess clinical tumor tissue for research use.
Tracking Information
- NCT #
- NCT02736357
- Collaborators
- Emory University
- University of Iowa
- M.D. Anderson Cancer Center
- Washington University School of Medicine
- University of Rochester
- Weill Medical College of Cornell University
- University of Miami
- Investigators
- Principal Investigator: James Cerhan, MD, PhD Mayo Clinic Principal Investigator: Christopher Flowers, MD Emory University
Get Well Soon